# Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC

> **NCT03145545** · — · AVAILABLE · sponsor: **Children's Hospital of Philadelphia**

## Conditions studied

- Leukemia
- Bone Marrow Failure Syndrome
- Immunodeficiencies

## Interventions

- **DEVICE:** Apha/beta T and CD19+ cell depletion using CliniMACS device

## Key facts

- **NCT ID:** NCT03145545
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03145545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03145545, "Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03145545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*